Compound Detail
CHEMBL61593
CYCLOTHIAZIDE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL61593 |
| Name | CYCLOTHIAZIDE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | BOCUKUHCLICSIY-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
8
Targets
16
Activities
2
Assay Types
0
PK Parameters
20
Publications
6
Known Names
1
Indications
1
Mechanisms
Molecular Properties
389.9
MW (Da)
1.23
ALogP
5
HBA
3
HBD
118.4
PSA (Ų)
0.66
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1982 |
| Availability | Discontinued |
| Chirality | Racemic |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Thiazide-sensitive sodium-chloride cotransporter inhibitor | INHIBITOR | Solute carrier family 12 member 3 | ✓ | ✓ |
Indications
Cardiovascular Diseases
ATC Classification
C03AA09
cyclothiazide
Level 1: CARDIOVASCULAR SYSTEM
Level 2: DIURETICS
Activity Summary
EC50 15 meas. best 6.0
IC50 1 meas. best 5.21
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Glutamate receptor 1 CHEMBL2009 | EC50 | 6.0 | 5.35 | 1000.0 | 4 |
| Glutamate receptor 2 CHEMBL4016 | EC50 | 5.65 | 5.385 | 2240.0 | 2 |
| Glutamate receptor 4 CHEMBL3190 | EC50 | 5.42 | 5.42 | 3800.0 | 2 |
| Unchecked CHEMBL612545 | EC50 | 5.41 | 5.2725 | 3910.0 | 4 |
| Glutamate receptor ionotropic, AMPA CHEMBL2093871 | IC50 | 5.21 | 5.21 | 6100.0 | 1 |
| Glutamate receptor AMPA 1/2 CHEMBL3883294 | EC50 | 5.18 | 5.18 | 6600.0 | 1 |
| Glutamate receptor 2 CHEMBL3503 | EC50 | 5.12 | 5.12 | 7600.0 | 1 |
| Glutamate receptor 3 CHEMBL3595 | EC50 | 4.86 | 4.86 | 13700.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine